Open-label phase II clinical trial of orteronel (TAK-700) in metastatic or advanced nonresectable granulosa cell ovarian tumors: The GREKO II study.
2014 ◽
Vol 32
(15_suppl)
◽
pp. TPS5626-TPS5626
Keyword(s):
Phase Ii
◽